PARAXYL CR 37.5MG

Here’s an SEO-friendly product description for Paraxyl CR 37.5 mg Tablets, ideal for online pharmacies, medical catalogs, or e-commerce platforms within Pakistan:

Paraxyl CR 37.5 mg Tablets – Extended‑Release Paroxetine SSRIs for Mood Disorders

Overview
Paraxyl CR 37.5 mg is an extended‑release tablet of paroxetine hydrochloride, a selective serotonin reuptake inhibitor (SSRI) designed for once-daily dosing. It helps manage various mental health conditions by increasing serotonin levels in the brain 

Key Indications

• Major Depressive Disorder (MDD)

• Generalized Anxiety Disorder (GAD)

• Social Anxiety Disorder (SAD)

• Panic Disorder (PD)

• Obsessive-Compulsive Disorder (OCD)

• Post-Traumatic Stress Disorder (PTSD)

• Premenstrual Dysphoric Disorder (PMDD) in women 

Benefits & Features

• Controlled‑release (CR) formulation ensures steady drug levels over 6–10 hours, minimizing peaks and troughsSingle daily tablet improves patient adherence.

• Particularly effective in conditions associated with anxiety and mood instability .

Typical Dosage

• Swallowed whole in the morning, with or without food.

• Initial doses often begin at 20 mg, increased gradually by 12.5 mg increments if needed, to a maximum of 37.5 mg for certain disorders like SAD or PMDD .

Possible Side Effects

• Common: nausea, drowsiness, dizziness, dry mouth, headache, insomnia, fatigue, sweating, sexual dysfunction (e.g. low libido or ejaculatory issues) .

• Rare but serious: serotonin syndrome (e.g. agitation, rapid heartbeat, fever), increased bleeding risk, mania, suicidal thoughts in younger patients .

Important Precautions

• Prescription-only medication; use only under medical supervision.

• Do not stop abruptly—gradual tapering is advised to avoid withdrawal symptoms like dizziness or agitation.

• Avoid concurrent use with MAO inhibitors—maintain a 14-day gap before or after switching medications .